Medical treatment of benign prostatic hyperplasia (BPH)
Journal Title: Postępy Nauk Medycznych - Year 2012, Vol 25, Issue 4
Abstract
Benign prostatic hyperplasia (BPH) is the most popular urological problem in men over the 50 years old. It is complex with regard to pathophysiology as well as signs and symptoms which differ among patients in intensity. The following elements create this entity i.e.: benign prostatic enlargement (BPE), benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS) which include storage and voiding symptoms. Diagnosis of prostatic enlargement, severity of LUTS and micturation objective parameters is simple.<br>Aims of BPH patients treatment are reduction of LUTS inhibition of progression and complications of the disease.<br>There are many commonly used methods of treatment of BPH, including pharmacotherapy. This review presents actual knowledge on pathopysiology and diagnosis of BPH, with emphasis on pharmacological treatment.
Authors and Affiliations
Tomasz Szopiński, Jakub Dobruch, Piotr Chłosta, Andrzej Borówka
Keywords
Related Articles
- EP ID EP54440
- DOI -
- Views 115
- Downloads 0
Squamous cell carcinoma of head and neck organs: contemporary management and perspectives
Some 5600 head and neck malignancies are diagnosed each year in Poland. Among them squamous cell carcinoma constitutes over 90%, and 40% are carcinomas of larynx. Risk factors are well-defined and contribute to relativel...
Całkowite zamknięcie tętnicy wieńcowej w ostrym zespole wieńcowym bez uniesienia odcinka st – analiza danych klinicznych i elektrokardiograficznych.
Hypocaloric diet and pharmacological treatment reduces body weight, insulin resistance and androgen levels and restore menstruation in obese women with polycystic ovary syndrome
Objective. To estimate the effects of the hypocaloric diet and pharmacological treatment with sibutramine on body weight, fat mass, especially abdominal fat, insulin resistance, serum androgens and menstruation pattern i...
Hypertension – diagnostic and therapeutic differencies in the elderly
According to WHO experts hypertension is the most common cause of mortality in global population. About 7.5 million people are dying every year because of the complications of hypertension. The frequency of hypertension...
Zespół Cushinga a choroby układu sercowo-naczyniowego
Przewlekła hiperkortyzolemia związana jest z licznymi powikłaniami ze strony układu sercowo-naczyniowego. Badania populacyjne wskazują na zwiększoną śmiertelność w grupie pacjentów z zespołem Cushinga. Głównymi przyczyna...